----

----

| DELAWARE                                                       | 65-0769296                           |
|----------------------------------------------------------------|--------------------------------------|
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
|                                                           |                                 |
| 5601 N. DIXIE HIGHWAY                                          |                                 |
| SUITE 411                                                      |                                 |
| FORT  LAUDERDALE, FLORIDA                            | 33334                                |
| (Address of principal executive offices)                       | (Zip Code)                           |

| Registrant’s telephone number, including area code:   | (954) 771-1772                                  |
|-------------------------------------------------------------|-------------------------------------------------|
| Securities registered pursuant to Section 12(b) of the Act: | None                                            |
| Securities registered pursuant to Section 12(g) of the Act: | Class A Common Stock, par value $0.01 per share |

----

----

----

| Large accelerated filer | o                                               | Accelerated filer         | o |
|-------------------------|-------------------------------------------------|---------------------------|---|
| Non-accelerated filer   | o (Do not check if a smaller reporting company) | Smaller reporting company | x |

----

----

| ITEM 10. | DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE |
|----------|--------------------------------------------------------|

| Name                |   | Age    |   | Position                                             |   | Since                                                        |
|---------------------|--------|--------|--------|------------------------------------------------------|--------|--------------------------------------------------------------|
|                |   |   |   |                                                 |   |                                                         |
| Timothy Lincoln     |   | 52     |   | Acting Principal Executive Officer, Class B Director |   | September 2002 – October 2006; and May 2009 to present |
|                |   |   |   |                                                 |   |                                                         |
| Mary E. Thomas      |   | 52     |   | Acting Principal Financial Officer Class A Director  |   | October 2000 (1) June 27, 2003                               |
|                |   |   |   |                                                 |   |                                                         |
| Jerome Fields, M.D. |   | 82     |   | Class B Director                                     |   | May 2006                                                     |

----

| ITEM 11. | EXECUTIVE COMPENSATION |
|----------|------------------------|

----

| Name and Principal Position        | Year   |   | Salary($) |    |   | Bonus($) |   |   | Option awards($) (1)(2) |   |   | Total  |   |
|------------------------------------|--------|--------|-----------|---------|--------|----------|--------|--------|-------------------------|--------|--------|--------|--------|
|                               |   |   |      |    |   |     |   |   |                    |   |   |   |   |
| Timothy Lincoln                    | 2010   |   |      | -0-     |   |     |   | -0-    |                    |   |   | -0-    |   |   |   | -0- |   |
| Acting Principal Executive Officer |   |   |      |    |   |     |   |   |                    |   |   |   |   |   |   |   |   |
|                               | 2009   |   |      | -0-     |   |     |   | -0-    |                    |   |   | -0-    |   |   |   | -0- |   |
|                               |   |   |      |    |   |     |   |   |                    |   |   |   |   |   |   |   |   |
| Donald J. Ciappenelli, Ph.D. (3)   | 2010   |   |      | -0-     |   |     |   | -0-    |                    |   |   | -0-    |   |   |   | -0- |   |
| Chief Executive Officer            |   |   |      |    |   |     |   |   |                    |   |   |   |   |   |   |   |   |
|                               | 2009   |   | $         | 158,308 |   |     |   | -0-    |                    |   |   | -0-    |   |   | $ | 158,308 |   |
|                               |   |   |      |    |   |     |   |   |                    |   |   |   |   |   |   |   |   |
| Howard Benjamin, Ph.D. (4)         | 2010   |   |      | -0-     |   |     |   | -0-    |                    |   |   | -0-    |   |   |   | -0- |   |
| Vice-President                     |   |   |      |    |   |     |   |   |                    |   |   |   |   |   |   |   |   |
|                               | 2009   |   | $         | 27,586  |   |     |   | -0-    |                    |   |   | -0-    |   |   | $ | 27,586 |   |
|                               |   |   |      |    |   |     |   |   |                    |   |   |   |   |   |   |   |   |
| Mary E. Thomas                     | 2010   |   | $         | 17,047  |   |     |   | -0-    |                    |   |   | -0-    |   |   | $ | 17,047 |   |
| Acting Principal Financial Officer |   |   |      |    |   |     |   |   |                    |   |   |   |   |   |   |   |   |
|                               | 2009   |   | $         | 20,630  |   |     |   | -0-    |                    |   |   | -0-    |   |   | $ | 20,630 |   |

| (1) | Except for stock options issued pursuant to the Company’s 1996, 1997, 1998, 1999 and 2006 Stock Option Plans, the Company has not provided benefits under any other long-term compensation plans, stock appreciation rights, defined benefit or actuarial plan.  Except pursuant to the employment agreement with Dr. Ciappenelli described below (which has been terminated), the Company does not have any employment contract or termination of employment or change in control agreement with any Named Executive Officer. |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2) | The amounts in this column (if any) do not reflect compensation actually received by the Named Executive Officer nor do they reflect the actual value that will be recognized by the Named Executive Officer.  Instead the amounts (if any) reflect the compensation cost recognized by the Company as of December 31, 2010 and 2009 for financial statement reporting purposes in accordance with ASC Topic 718 Share-Based Payment.  For information regarding the assumptions made in calculating the amounts reflected in this column, see Footnote 7 – Stock Based Compensation, to our audited consolidated financial statements for the year ended December 31, 2010, included in our Annual Report on Form 10-K for the year ended December 31, 2010. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (3) | Dr. Ciappenelli was appointed as the Company’s Chief Executive Officer effective November 1, 2006.  Dr. Ciappenelli received a grant of options to purchase 2,775,350 shares of Class A Common Stock, 925,117 of which were immediately exercisable.  An additional 925,117 of the options were exercisable on November 1, 2007, and the remaining 925,116 were exercisable on November 1, 2009.  The exercise price of the options was $0.079 per share and the expiration date of the grant was November 1, 2016.  Dr. Ciappenelli ended his employment with the Company in May 2009, and all of his unexercised stock options have been forfeited. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (4) | Dr. Benjamin was appointed Vice-President of the Company effective March 5, 2007.  Dr. Benjamin received a grant of options to purchase 683,238 shares of Class A Common Stock, 227,746 of which were immediately exercisable.  The exercise price of the options was $0.80 per share and the expiration date of the grant is March 5, 2017.  On December 8, 2008, Dr. Benjamin resigned from the Company with an effective date of January 2, 2009.   All of Dr. Benjamin’s unexercised stock options expired on February 1, 2009, and are no longer exercisable. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| Director Compensation |
|-----------------------|
|                  |
| Name                  | Fees Earned or Paid in Cash | Stock Awards | Option Awards | Non-Equity Incentive Plan Compensation | Nonqualified Deferred Compensation Earnings | All Other Compensation | Total |
|                  |   |   |   |   |   |   |   |
| Jerome Fields, M.D.   | $500(1) | -0- | -0- | -0- | -0- | -0- | $500 |
|                  |   |   |   |   |   |   |   |
| Timothy Lincoln       | -0- | -0- | -0- | -0- | -0- | -0- | -0- |

|   | (1) | A director fee of $500 was paid to Dr. Fields for attendance at the 2010 annual meeting of stockholders. |
|--------|-----|----------------------------------------------------------------------------------------------------------|

----

| ITEM 12. | SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS |
|----------|------------------------------------------------------------------------------------------------|

| Plan Category                                         | Number of securities to be issued upon exercise of outstanding options, warrants and rights | Weighted average exercise price of outstanding options, warrants and rights | Number of securities remaining available for future issuance under equity compensation plans |
|------------------------------------------------------------|---------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------|----------------------------------------------------------------------------------------------|
| Equity compensation plans approved by security holders     | -0-                                                                                         | -                                                                           | 10,100,000                                                                                   |
| Equity compensation plans not approved by security holders | -                                                                                           | -                                                                           | -                                                                                            |
| TOTAL                                                      | -0-                                                                                         | -                                                                           | 10,100,000                                                                                   |

| Name (1)                    | CurrentTitle      | SharesBeneficiallyOwned | Percentage ofClass BeneficiallyOwned | TitleOfClass       |
|-----------------------------|-------------------|-------------------------|--------------------------------------|--------------------|
|                        |              |                    |                                 |               |
|                        |              | 62,597,409(2)           | 96.01%                               | Class A Common     |
| M. Lee Pearce, M.D.         |              | 25,000 (3)              | 100%                                 | Class B Common     |
|                        |              | 2,170 (4)               | 100%                                 | Series B Preferred |
|                        |              |                    |                                 |               |
| Timothy C. Lincoln          | Class B Director, | 1,053                   | *                                    | Class A Common     |
|                        | Acting Principal  |                    |                                 |               |
|                        | Executive Officer |                    |                                 |               |
|                        |              |                    |                                 |               |
|                        | Class A Director, | -0-                     | *                                    | Class A Common     |
| Mary E. Thomas              | Acting Principal  |                    |                                 |               |
|                        | Financial Officer |                    |                                 |               |
|                        |              |                    |                                 |               |
| Jerome Fields, M.D.         | Class A Director  | 100,000                 | *                                    | Class A Common     |
|                        |              |                    |                                 |               |
| All Directors and Executive |              | 101,053                 | *                                    | Class A Common     |
| Officers as a Group         |              |                    |                                 |               |
| (3  Persons)      |              |                    |                                 |               |

----

| (1) | The address for all persons listed above is c/o Le@P Technology, Inc., 5601 N. Dixie Highway, Suite 411, Fort Lauderdale, Florida 33334. |
|-----|------------------------------------------------------------------------------------------------------------------------------------------|

| (2) | The shares of Class A Common Stock beneficially owned by Dr. Pearce include:  (i) 59,897,409 shares owned by the M. Lee Pearce Living Trust, of which Dr. Pearce is the 100% beneficial owner, (ii) 2,000,000 shares owned by PearTan, LLC, of which Dr. Pearce is the sole member, (iii) 700,000 shares owned by Broward Trading Corporation, of which Dr. Pearce is the sole shareholder, and (iv) 25,000 shares held by Dr. Pearce directly.  The calculation of Dr. Pearce’s beneficial ownership percentage does not take into account the exercise of options, if any, held by third parties, including options held by officers and directors. |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (3) | These shares of Class B Common Stock are owned by Lauderdale Holdings, Inc. (“LHI”), a Florida corporation, of which Dr. Pearce is the sole shareholder. |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (4) | These shares of Series B Preferred Stock do not have voting rights, and thus will not be eligible to vote at any meeting of stockholders (including the annual meeting), and are held by the M. Lee Pearce Living Trust, of which Dr. Pearce is the 100% beneficial owner. |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ITEM 13. | CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE |
|----------|---------------------------------------------------------------------------|

----

----

| ITEM 14. | PRINCIPAL ACCOUNTANT FEES AND SERVICES |
|----------|----------------------------------------|

| ITEM 15. | EXHIBITS AND FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON FORM 8-K |
|----------|---------------------------------------------------------------------|

| (a)(3) | Exhibit Index. |
|--------|----------------|

----

| EXHIBIT |   | DESCRIPTION                                                                                                                                                                                                                                                                                                                                                                                          |
|---------|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                 |
| 3.1.1   |   | Certificate of Incorporation of Le@P Technology, Inc., filed March 20, 1997 with the Delaware Secretary of State (incorporated by reference to Appendix B to the Company’s Definitive Proxy Statement for the Annual Meeting of Stockholders, as filed with the Securities Exchange Commission (the “SEC”) on April 11, 1997).                                                     |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                 |
| 3.1.2   |   | Certificate of Ownership and Merger of Seal Holdings Corporation filed with the Delaware Secretary of State on June 13, 1997 (incorporated by reference to Exhibit 3.1.2 to the Company’s Annual Report on Form 10-KSB for the year ended December 31, 2005, as filed with the SEC on March 27, 2006).                                                                                         |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                 |
| 3.1.3   |   | Certificate of Preferred Stock Designation of Le@P Technology, Inc. filed with the Delaware Secretary of State on March 23, 1999 (incorporated by reference to Exhibit 3.3 to the Company’s Current Report on Form 8-K, as filed with the SEC on April 19, 1999).                                                                                                                              |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                 |
| 3.1.4   |   | Certificate of Amendment to Certificate of Incorporation of Le@P Technology, Inc. filed June 21, 1999 with the Delaware Secretary of State (incorporated by reference to Exhibit 3.1.3 to the Company’s Annual Report on Form 10-KSB for the year ended December 31, 1999, as filed with the SEC on March 30, 2000).                                                                           |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                 |
| 3.1.5   |   | Certificate of Designation, Preferences, Rights and Limitations of 10% Cumulative Non-Voting Series B Preferred Stock of Le@P Technology, Inc. filed with the Delaware Secretary of State on November 15, 1999 (incorporated by reference to Exhibit 4 to the Company’s Quarterly Report on Form 10-QSB for the quarter ended September 30, 1999, as filed with the SEC on November 15, 1999). |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                 |
| 3.1.6   |   | Certificate of Amendment to Certificate of Incorporation of Le@P Technology, Inc. filed July 5, 2000 with the Delaware Secretary of State (incorporated by reference to Exhibit 3 to the Company’s Quarterly Report on Form 10-QSB for the quarter ended June 30, 2000, as filed with the SEC on August 14, 2000).                                                                             |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                 |
| 3.2     |   | Bylaws of Le@P Technology, Inc.(incorporated by reference to Appendix C to the Company’s Proxy Statement for the Annual Meeting of Stockholders of Le@P Fleet, Inc. held May 14, 1997, as filed with the SEC on April 11, 1997).                                                                                                                                                               |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                 |
| 10.1    |   | Funding Arrangement by M. Lee Pearce, M.D. (incorporated by reference to Exhibit 99.1 to the Company’s Current Report on Form 8-K dated October 15, 1999).                                                                                                                                                                                                                                     |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                 |
| 10.2    |   | Subscription Agreement dated March 30, 2000 with M. Lee Pearce, M.D. (incorporated by reference to Exhibit 10.2 in the Company’s Annual Report on From 10-KSB for the fiscal year ended December 31, 2000 dated March 30, 2001).                                                                                                                                                               |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                 |
| 10.3    |   | 1999 Long Term Incentive Plan (incorporated by reference to Exhibit B to the Company’s Definitive Proxy Statement for its Annual Meeting of Stockholders dated June 4, 1999).                                                                                                                                                                                                                  |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                 |
| 10.4    |   | 1998 Incentive Option Plan (incorporated by reference to Exhibit A to the Company’s Definitive Proxy Statement for its Annual Meeting of Stockholders dated June 8, 1998).                                                                                                                                                                                                                     |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                 |
| 10.5    |   | 1997 Incentive Option Plan (incorporated by reference to Appendix A to the Company’s Definitive Proxy Statement for its Annual Meeting of Stockholders dated April 11, 1997).                                                                                                                                                                                                                  |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                 |
| 10.6    |   | Amended 1996 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.3 to the Company’s Form 10-Q for the quarter ended March 31, 1997 dated May 15, 1997).                                                                                                                                                                                                                          |

----

| 10.7   |   | Stock Exchange and Merger Agreement dated as of January 7, 2005 among Healthology, Inc., iVillage, Inc., Virtue Acquisition Corporation and certain stockholders of Healthology, Inc., including the Company (incorporated by reference to Exhibit 10.34 in the Company’s Annual Report on Form 10-KSB for the fiscal year ended December 31, 2004 dated March 30, 2005). |
|--------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |   |                                                                                                                                                                                                                                                                                                                                                                            |
| 10.8   |   | Stock Purchase Agreement dated as of January 7, 2005 between the Company and Steven Haimowitz (incorporated by reference to Exhibit 10.35 in the Company’s Annual Report on Form 10-KSB for the fiscal year ended December 31, 2004 dated March 30, 2005).                                                                                                                |
|   |   |                                                                                                                                                                                                                                                                                                                                                                            |
| 10.9   |   | Exchange and Termination Agreement dated March 17, 2006, effective as of March 15, 2006, between Le@P Technology, Inc. and the M. Lee Pearce 2005 Irrevocable Trust (incorporated by reference to Exhibit 10.1 in the Company’s Current Report on Form 8-K dated March 21, 2006).                                                                                         |
|   |   |                                                                                                                                                                                                                                                                                                                                                                            |
| 10.10  |   | Fairness Opinion dated March 15, 2006 issued by Stenton Leigh Valuation Group, Inc. on March 16, 2006 (incorporated by reference to Exhibit 10.2 in the Company’s Current Report on Form 8-K dated March 21, 2006).                                                                                                                                                       |
|   |   |                                                                                                                                                                                                                                                                                                                                                                            |
| 10.11  |   | Employment Agreement, dated as of November 1, 2006 by and between Le@P Technology, Inc. and Dr. Donald J. Ciappenelli (incorporated by reference to Exhibit 10.1 in the Company’s Current Report on Form 8-K dated November 3, 2006)                                                                                                                                      |
|   |   |                                                                                                                                                                                                                                                                                                                                                                            |
| 10.12  |   | Employment Agreement, dated as of March 5, 2007 by and between Le@P Technology, Inc. and Dr. Howard Benjamin. (incorporated by reference to Exhibit 10.33 in the Company’s Annual Report on Form 10-KSB dated March 30, 2007)                                                                                                                                             |
|   |   |                                                                                                                                                                                                                                                                                                                                                                            |
| 10.13  |   | Renewal Promissory Note dated as of October 24, 2007 in the principal amount of $562,500 executed by Parkson, LLC in favor of Bay Colony Associates, Ltd. (incorporated by reference to Exhibit 10.1 in the Company’s Current Report on Form 8-K dated October 25, 2007).                                                                                                 |
|   |   |                                                                                                                                                                                                                                                                                                                                                                            |
| 10.14  |   | Promissory Note dated March 3, 2010 in the principal amount of $130,000 in favor of M. Lee Pearce Living Trust (incorporated by reference to Exhibit 10.38 in the Company’s Current Report on Form 10-Q as filed on May 12, 2010).                                                                                                                                        |
|   |   |                                                                                                                                                                                                                                                                                                                                                                            |
| 10.15  |   | Renewal Note dated January 31, 2011 in the principal amount of $99,319.39 in favor of M. Lee Pearce Living Trust (incorporated by reference to Exhibit 10.2 in the Company’s Current Report on Form 8-K dated February 1, 2011).                                                                                                                                          |
|   |   |                                                                                                                                                                                                                                                                                                                                                                            |
| 10.16  |   | Renewal Note dated January 31, 2011 in the principal amount of $562,500 in favor of Bay Colony Associates, Ltd. (incorporated by reference to Exhibit 10.1 in the Company’s Current Report on Form 8-K dated February 1, 2011).                                                                                                                                           |
|   |   |                                                                                                                                                                                                                                                                                                                                                                            |
| 10.17  |   | Promissory Note dated September 1, 2010 in the principal amount of $60,000 in favor of M. Lee Pearce Living Trust.*                                                                                                                                                                                                                                                             |
|   |   |                                                                                                                                                                                                                                                                                                                                                                            |
| 10.18  |   | Promissory Note dated January 6, 2011 in the principal amount of $125,000 in favor of M. Lee Pearce Living Trust.*                                                                                                                                                                                                                                                              |
|   |   |                                                                                                                                                                                                                                                                                                                                                                            |
| 21     |   | Subsidiaries of the Registrant.*                                                                                                                                                                                                                                                                                                                                                |
|   |   |                                                                                                                                                                                                                                                                                                                                                                            |
| 31.1   |   | Certification of the Acting Principal Executive Officer pursuant  to Section 302 of the Sarbanes-Oxley Act of 2002.**                                                                                                                                                                                                                                                 |
|   |   |                                                                                                                                                                                                                                                                                                                                                                            |
| 31.2   |   | Certification of the Acting Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.**                                                                                                                                                                                                                                                            |

----

| 32     |   | Certification of the Acting Principal Executive Officer and the Acting Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**                                                                                   |
|--------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |   |                                                                                                                                                                                                                                              |
| 99.1   |   | Current Report on Form 8-K dated January 28, 2011, relating to an event dated January 25, 2011.  Pursuant to Item 4.01 of such Current Report, the Registrant reported the change in Registrant’s Certifying Accountants*         |
|   |   |                                                                                                                                                                                                                                              |
| 99.2   |   | Current Report on Form 8-K dated February 1, 2011, relating to an event dated January 31, 2011.  Pursuant to Item 1.01 of such Current Report, the Registrant reported the renewal of a promissory note to Bay Colony Associates, Ltd.* |

----

|   | LE@P TECHNOLOGY, INC. |
|--------|-----------------------|
|   |                  |   |
|   | By:                   | /s/Timothy Lincoln |
|   |                  | Timothy Lincoln, |
|   |                  | Acting Principal Executive Officer |
|   |                  |   |
|   |                  |   |
|   | By:                   | /s/ Mary E. Thomas |
|   |                  | Mary E. Thomas, |
|   |                  | Acting Principal Financial Officer |

| SIGNATURE               |   | TITLE                                           |   | DATE        |
|-------------------------|--------|-------------------------------------------------|--------|-------------|
|                    |   |                                            |   |        |
| /s/ Timothy Lincoln     |   | Acting Principal Executive Officer and Director |   | May 2, 2011 |
| Timothy Lincoln         |   |                                            |   |        |
|                    |   |                                            |   |        |
| /s/ Mary E. Thomas      |   | Acting Principal Financial Officer and Director |   | May 2, 2011 |
| Mary E. Thomas          |   |                                            |   |        |
|                    |   |                                            |   |        |
| /s/ Jerome Fields, M.D. |   | Director                                        |   | May 2, 2011 |
| Jerome Fields, M.D.     |   |                                            |   |        |

----